BioSpace News Archive

Deals

Quest Diagnostics to Acquire Outreach Lab Services Business of Summa Health

Quest Diagnostics and Summa Health today announced a definitive agreement for Quest to acquire select assets of Summa Health’s outreach laboratory services business, referred to as LabCare Plus, in an all-cash transaction.

October 5, 2022
·
3 min read
Drug Development

ABVC BioPharma Announces Vitargus® Phase II Study Plan Approved by HREC in Australia

ABVC Biopharma, Inc. today announced that its Vitrargus Phase II study plan was approved by the Australian Bellberry Human Research Ethics Committee (HREC) on September 29, 2022.

October 5, 2022
·
3 min read
Business

Evaxion welcomes Per Norlén as new CEO.

Evaxion Biotech A/S announces that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd.

October 5, 2022
·
5 min read
Pharm Country

MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

MiNK Therapeutics, Inc. announced the acceptance of five abstracts for presentation at the Society for Immunotherapy of Cancer’s 37th Annual Meeting, to be held November 8 – 12th, 2022.

October 5, 2022
·
2 min read
Genetown

Acer Therapeutics Announces Expansion of ACER-801 (osanetant) Development Indications to Include Post-Traumatic Stress Disorder

Acer Therapeutics Inc. today announced the expansion of ACER-801 (osanetant) into a new indication, for the reduction of the frequency and severity of acute stress disorder and post-traumatic stress disorder (PTSD).

October 5, 2022
·
7 min read
BioMidwest

Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Daxor Corporation announces that a scientific session titled “Debating Volume-based versus Pressure-based Methods and Devices to Measure Congestion in Heart Failure” was held during the Heart Failure Society of America Annual Scientific Meeting on October 3rd, 2022, in Washington, DC.

October 5, 2022
·
4 min read
Bio NC

Thermo Fisher Scientific Introduces Decentralized Clinical Trials Network

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced the creation of the PPD DCT Network to support global investigators and research sites participating in decentralized clinical trials (DCTs) for pharmaceutical and biotech customers.

October 5, 2022
·
3 min read
DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa

DiscGenics, Inc. today announced that Flagg Flanagan, Chief Executive Officer and Chairman will present virtually at the annual Cell & Gene Meeting on the Mesa to be held October 11-13 in Carlsbad, California and livestreamed globally.

October 5, 2022
·
2 min read
Business

Prenosis Announces New Board Members

Prenosis, Inc. today announced four new members to its Board of Directors and nine members to its Clinical & Scientific Board.

October 5, 2022
·
5 min read
Drug Development

Alzamend Neuro Announces Addition of Healthy Subjects to Ongoing Phase IIA Clinical Trial for AL001 in Alzheimer’s Subjects

Alzamend Neuro, Inc. today announced it has dosed its first healthy adult subject in its Phase IIA multiple ascending dose (“MAD”) study of AL001 in subjects with dementia related to Alzheimer’s.

October 5, 2022
·
4 min read